⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight
globenewswire.com
LLY
MRK
GSK
BMY
AZN
PFE
NVO
REGN
RDHL
AGIO
INCY
CRBP
BMRN
VKTX
RIGL
DTIL
CRDF
BIIB
ALKS
EXAS
CLDX
SRPT
TGTX
ALNY
CHKP
TAK
HHS
SERV
GILD
HRMY
IONS
BH
FORM
JNJ
GEN
ABBV
AMGN
CRSP
CHRD
ADPT
IMUX
ALGN
EXEL
VRTX
Atherosclerotic Cardiovascular Disease (ASCVD) Market Insights, Epidemiology, and Forecast - 2036 | 7MM Market to Reach USD 40 Billion as Precision Therapies Reshape Growth
globenewswire.com
AMGN
ARWR
NVS
ALNY
SNY
REGN
ESPR
JNJ
AZN
AMRN
MRK
LLY
BMY
ON
NVO
Coronary Artery Disease Clinical Trial Space Intensifies with 20+ Companies in Active Development | DelveInsight
globenewswire.com
CYTK
NVO
BCDA
AZN
MESO
GEHC
BSX
MDT
ABT
LIVN
OSCR
EL
BMY
ARE
AVT
RNTX
Ro and Novo Announce Research Collaboration to Generate First-of-its-Kind Real-World Evidence on the Wegovy® Pill
prnewswire.com
NVO
Novo’s Ozempic® (semaglutide) 2 mg associated with lower risk of major adverse cardiovascular events (death, heart attack, and stroke) in adults with type 2 diabetes compared to switching to Mounjaro® (tirzepatide), in real-world analysis
globenewswire.com
NVO
Novo and Hengrui Pharma enter exclusive license agreement for once-weekly oral GLP-1/GIP dual receptor agonist HRS-1596
globenewswire.com
NVO
Inagene launches GLP-1 Insights Program combining genetic insights with registered dietitian support to help Canadians understand their genetic response to weight management and diabetes medications
globenewswire.com
NVO
LLY
Obesity Treatment Landscape 2026: Obesity Competitive Landscape and Clinical Trial Analysis 2026 Examines 200+ Companies and 200+ Drugs
globenewswire.com
LLY
NVO
NBIX
WVE
ALV
PFE
ABBV
AMGN
VKTX
ALNY
Global Alzheimer’s Disease Biomarker Market Poised for Phenomenal Expansion at a Growth Rate of ~9% by 2034 | DelveInsight
globenewswire.com
ABT
BIO
AMGN
BMY
AXSM
JNJ
LLY
NVO
QTRX
DGX
TMO
QRVO
GILD
REGN
BIIB
ALKS
ACAD
PTGX
CRIS
EXAS
TDOC
QRHC
AMZN
GOOG
MSFT
IBM
NVDA
INTC
AMD
QCOM
AMAT
LRCX
KLAC
MU
ADI
NXPI
TXN
MRVL
ON
CDNS
SNPS
MCHP
AEHR
ENPH
PLUG
FCEL
PLTR
AI
CRBU
EDIT
BEAM
NTLA
BNTX
MRNA
PFE
JAZZ
ACGL
ZBRA
MSCI
ROST
SWKS
MDT
TNDM
XRAY
ALGN
IDXX
EXPE
CTAS
ILMN
DXCM
ASML
ADBE
Metabolic Dysfunction-Associated Steatohepatitis Competitive Landscape and Clinical Trial Analysis Report 2026 Assesses 180+ Companies and 200+ Drugs
globenewswire.com
MDGL
NVO
GSK
ALT
GALT
VKTX
CRBP
CANF
BILI
MRK